Junliang Lu
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 19
- Pancreatic and Hepatic Oncology Research 6
- Colorectal Cancer Treatments and Studies 3
-
- Cancer Genomics and Diagnostics 6
- Breast Cancer Treatment Studies 3
- Co-authors
- Zhiyong Liang (29 shared papers)Huanwen Wu (23 shared papers)Jian Sun (10 shared papers)Huanli Duan (7 shared papers)Tonghua Liu (5 shared papers)Xinyu Ren (5 shared papers)Hui Zhang (7 shared papers)Tao Lu (4 shared papers)
- Journals
- Cancer Letters (4 papers)Diagnostic Pathology (3 papers)Scientific Reports (2 papers)Human Pathology (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Junliang Lu
47 papers receiving 991 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 208
- Oncology 363
- Endocrinology, Diabetes and Metabolism 135
- Pathology and Forensic Medicine 138
- Nephrology 36
Countries citing papers authored by Junliang Lu
This map shows the geographic impact of Junliang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junliang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junliang Lu more than expected).
Fields of papers citing papers by Junliang Lu
This network shows the impact of papers produced by Junliang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junliang Lu. The network helps show where Junliang Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junliang Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 100 | |
| 2 | 2023 | 75 | |
| 3 | 2017 | 72 | |
| 4 | 2016 | 56 | |
| 5 | 2018 | 46 | |
| 6 | 2019 | 45 | |
| 7 | 2020 | 43 | |
| 8 | 2017 | 38 | |
| 9 | Comparison of EGFR mutation status between plasma and tumor tissue in non-small cell lung cancer using the Scorpion ARMS method and the possible prognostic significance of plasma EGFR mutation status. | 2015 | 34 |
| 10 | 2016 | 33 | |
| 11 | 2016 | 33 | |
| 12 | 2018 | 29 | |
| 13 | 2012 | 29 | |
| 14 | 2017 | 28 | |
| 15 | Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma. | 2015 | 27 |
| 16 | 2016 | 24 | |
| 17 | Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma. | 2015 | 22 |
| 18 | 2016 | 21 | |
| 19 | 2021 | 18 | |
| 20 | [Thyroid squamous-cell carcinoma showing thymus-like element (CASTLE): a report of eight cases]. | 1999 | 17 |
About Junliang Lu
Junliang Lu is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 48 papers that have together received 1000 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers), Genetic factors in colorectal cancer (4 papers), Breast Cancer Treatment Studies (3 papers), Fibroblast Growth Factor Research (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Cancer Research (208 citations), Oncology (363 citations), Endocrinology, Diabetes and Metabolism (135 citations), Pathology and Forensic Medicine (138 citations) and Nephrology (36 citations). Junliang Lu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhiyong Liang, Huanwen Wu, Jian Sun, Huanli Duan, Tonghua Liu, Xinyu Ren, Hui Zhang, Tao Lu, Jie Gao and Jing Zhang. Their work appears in journals such as Cancer Letters, Diagnostic Pathology, Scientific Reports, Human Pathology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.